MiR-142 inhibits the development of cervical cancer by targeting HMGB1

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are implicated in various human cancers, including cervical cancer.
• The precise roles and mechanisms of miR-142 in cervical cancer progression remain unclear.

Purpose of the Study:

• To investigate the clinical significance and molecular mechanisms of miR-142 in human cervical cancer.
• To determine if miR-142 functions as a tumor suppressor in cervical cancer.

Main Methods:

• Quantitative real-time PCR to assess miR-142 expression in cervical cancer tissues and cell lines.
• Correlation analysis between miR-142 expression and clinical parameters (FIGO stage, lymphatic metastasis).
• Functional assays (proliferation, invasion, apoptosis) in SiHa and HeLa cells with miR-142 overexpression.
• Luciferase reporter assays and Western blotting to identify and validate HMGB1 as a direct target of miR-142.

Main Results:

• miR-142 expression was significantly downregulated in cervical cancer tissues and cell lines.
• Lower miR-142 levels correlated with advanced FIGO stage and lymphatic metastasis.
• Overexpression of miR-142 suppressed cell proliferation and invasion, while enhancing apoptosis in cervical cancer cells.
• High-mobility group box 1 protein (HMGB1) was identified as a direct target of miR-142, with inverse expression correlation.
• Ectopic HMGB1 expression counteracted the tumor-suppressive effects of miR-142.

Conclusions:

• miR-142 acts as a tumor suppressor in cervical cancer by inhibiting cell proliferation and invasion and promoting apoptosis.
• These effects are mediated through the direct targeting of HMGB1.
• miR-142-HMGB1 axis represents a potential therapeutic strategy for cervical cancer.